Your browser doesn't support javascript.
loading
Evaluation of PNU-159682 antibody drug conjugates (ADCs).
Holte, Dane; Lyssikatos, Joseph P; Valdiosera, Amanda M; Swinney, Zachary; Sisodiya, Vikram; Sandoval, Joseph; Lee, Christina; Aujay, Monette A; Tchelepi, Robert B; Hamdy, Omar M; Gu, Christine; Lin, Baiwei; Sarvaiya, Hetal; Pysz, Marybeth A; Laysang, Amy; Williams, Samuel; Jun Lee, Dong; Holda, Magda K; Purcell, James W; Gavrilyuk, Julia.
Afiliação
  • Holte D; AbbVie Chemical Development & Manufacturing, 995 East Arques Avenue, Sunnyvale, CA 94085, USA. Electronic address: dane.holte@abbvie.com.
  • Lyssikatos JP; Enliven Therapeutics, 6200 Lookout Road, First Floor, Boulder, CO 80301, USA.
  • Valdiosera AM; Parvus Therapeutics, 800 Dubuque Avenue, South San Francisco, CA 94080, USA.
  • Swinney Z; Mantra Bio, 455 Mission Bay Boulevard, South San Francisco, CA 94158, USA.
  • Sisodiya V; Denali Therapeutics, 161 Oyster Point Bloulevard, South San Francisco, CA 94080, USA.
  • Sandoval J; Fate Therapeutics, 3535 General Atomics Court, Suite 200, San Diego 92121, USA.
  • Lee C; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
  • Aujay MA; Enliven Therapeutics, 6200 Lookout Road, First Floor, Boulder, CO 80301, USA.
  • Tchelepi RB; Bolt Biotherapeutics, 640 Galveston Drive, Redwood City, CA 94063, USA.
  • Hamdy OM; Applied Molecular Transport, 1 Tower Place, Suite 850, South San Francisco, CA 94080, USA.
  • Gu C; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA; AbbVie Research & Development, 995 East Arques Avenue, Sunnyvale, CA 94085, USA.
  • Lin B; Maze Therapeutics, 131 Oyster Point Blvd, Suite 200, South San Francisco, CA 94080, USA.
  • Sarvaiya H; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
  • Pysz MA; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
  • Laysang A; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
  • Williams S; ArsenalBio, Inc. 2 Tower Place, South San Francisco, CA 94080, USA.
  • Jun Lee D; AbbVie Research & Development, 995 East Arques Avenue, Sunnyvale, CA 94085, USA.
  • Holda MK; AbbVie Research & Development, 1500 Seaport Blvd, Redwood City, CA 94063, USA.
  • Purcell JW; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
  • Gavrilyuk J; AbbVie Research & Development, 400 East Jamie Court, South San Francisco, CA 94080, USA.
Bioorg Med Chem Lett ; 30(24): 127640, 2020 12 15.
Article em En | MEDLINE | ID: mdl-33127540
ABSTRACT
PNU-159682 is a highly potent secondary metabolite of nemorubicin belonging to the anthracycline class of natural products. Due to its extremely high potency and only partially understood mechanism of action, it was deemed an interesting starting point for the development of a new suite of linker drugs for antibody drug conjugates (ADCs). Structure activity relationships were explored on the small molecule which led to six linker drugs being developed for conjugation to antibodies. Herein we describe the synthesis of novel PNU-159682 derivatives and the subsequent linker drugs as well as the corresponding biological evaluations of the small molecules and ADCs.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doxorrubicina / Imunoconjugados / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doxorrubicina / Imunoconjugados / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article